Get the Stockscreener App
98.67
0.88%
0.88
After Hours:
98.99
0.32
+0.32%
Boston Scientific Corp stock is traded at $98.67, with a volume of 8.14M.
It is up +0.88% in the last 24 hours and up +1.16% over the past month.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
See More
Previous Close:
$97.79
Open:
$98.28
24h Volume:
8.14M
Relative Volume:
0.94
Market Cap:
$146.27B
Revenue:
$19.35B
Net Income/Loss:
$2.78B
P/E Ratio:
52.78
EPS:
1.8696
Net Cash Flow:
$3.82B
1W Performance:
+3.46%
1M Performance:
+1.16%
6M Performance:
-4.99%
1Y Performance:
+7.24%
1-Day Range:
$98.12
$99.15
1-Week Range:
$93.86
$99.15
52-Week Range:
$85.98
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Name
Boston Scientific Corp
Sector
Industry
Phone
508-683-4000
Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
98.67 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
ABT
Abbott Laboratories
|
127.03 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
367.58 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.76 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.85 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-03-25 | Downgrade | Erste Group | Buy → Hold |
| Sep-08-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jun-16-25 | Initiated | Leerink Partners | Outperform |
| Apr-16-25 | Upgrade | Needham | Hold → Buy |
| Jan-10-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Oct-18-24 | Downgrade | Needham | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| Feb-01-24 | Upgrade | Mizuho | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-22-22 | Initiated | Mizuho | Neutral |
| Dec-20-22 | Resumed | Citigroup | Buy |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-27-22 | Upgrade | Needham | Hold → Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| May-26-21 | Downgrade | Needham | Buy → Hold |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-22-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-01-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Buy |
| Dec-30-19 | Reiterated | Cowen | Outperform |
| Dec-19-19 | Downgrade | Needham | Strong Buy → Buy |
| Sep-05-19 | Resumed | JP Morgan | Overweight |
| Sep-03-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Oct-02-18 | Reiterated | Morgan Stanley | Overweight |
| Sep-07-18 | Reiterated | Needham | Strong Buy |
| Sep-04-18 | Upgrade | Jefferies | Hold → Buy |
| Jul-06-18 | Reiterated | Needham | Strong Buy |
| Jun-27-18 | Initiated | Bernstein | Outperform |
| Apr-26-18 | Reiterated | Needham | Strong Buy |
View All
Boston Scientific Corp Stock (BSX) Latest News
Boston Scientific’s AXIOS™ Gastroenterostomy Trial Paused: What Investors Should Watch - TipRanks
Boston Scientific (BSX) Just Overtook the 50-Day Moving Average - Yahoo Finance
If You Invested $1000 in Boston Scientific 10 Years Ago, This Is How Much You'd Have Now - Yahoo Finance
Med tech company begins renovations for new South Congress offices - Austin American-Statesman
We Think Boston Scientific (NYSE:BSX) Can Manage Its Debt With Ease - Yahoo Finance
Boston Scientific Corporation (BSX) Stock Analysis: A 32.89% Potential Upside Beckons Investors - DirectorsTalk Interviews
Boston Scientific Stock: Steady Beat, Subtle Volatility – What The Market Is Really Pricing In - AD HOC NEWS
JARISLOWSKY FRASER Ltd Trims Stake in Boston Scientific Corporation $BSX - MarketBeat
Synergy Asset Management LLC Acquires 479,593 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp Is Quietly Winning Wall Street – But Is BSX Actually Worth Your Money? - AD HOC NEWS
Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results - Finviz
Boston Scientific sets dates to reveal its 2025 financial results - Stock Titan
A Look Into Boston Scientific Inc's Price Over Earnings - Benzinga
Vanderbilt University Has $2.55 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
How Is Boston Scientific's Cardiovascular Growth Path Shaping Up? - The Globe and Mail
Calamos Wealth Management LLC Buys 53,252 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Sold by Boston Trust Walden Corp - MarketBeat
Boston Scientific Corporation $BSX Shares Purchased by Allspring Global Investments Holdings LLC - MarketBeat
Does Boston Scientific (NYSE:BSX) Deserve A Spot On Your Watchlist? - Yahoo Finance
Boston Scientific Corp. stock: quiet tape, loud expectations as Wall Street leans bullish - AD HOC NEWS
Sowell Financial Services LLC Sells 28,806 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Stock Position Lessened by Ethic Inc. - MarketBeat
Boston Scientific Corporation (NYSE:BSX) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
CathVision Announces Appointment of Eric Thepaut as Independent Chairman of the Board and Releases ECGenius® System Version 3.5 - Quantisnow
Boston Scientific Corporation (BSX) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
A Strong Growth Profile Gives Boston Scientific Corp. (BSX) a Favorable Outlook - Insider Monkey
VCI Wealth Management LLC Invests $1.26 Million in Boston Scientific Corporation $BSX - MarketBeat
Norden Group LLC Increases Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Acquired by Brookstone Capital Management - MarketBeat
What Analysts Think Is Changing In The Boston Scientific Growth Story - Yahoo Finance
Should New Institutional Support and Analyst Optimism Around Farapulse Reshape Boston Scientific (BSX) Investors’ Thesis? - Yahoo Finance
Does Boston Scientific’s Strong Run Match Its Current Valuation in 2025? - simplywall.st
Boston Scientific (BSX) Stock After Hours on Dec. 24, 2025: Key Moves, Today’s Fresh Analysis, and What to Watch Before Markets Reopen - ts2.tech
Boston Scientific (BSX): Assessing Valuation After a Strong Multi‑Year Run and Recent Pullback - Yahoo Finance
How Well Is Boston Scientific Placed for Long-Term Endoscopy Growth? - Yahoo Finance
Boston Scientific Corporation $BSX is Munro Partners' 8th Largest Position - MarketBeat
Exchange Traded Concepts LLC Boosts Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific head of cardiac rhythm management, diagnostics to retire, successor named - MassDevice
Westwind Capital Takes $13.80 Million Position in Boston Scientific Corporation $BSX - MarketBeat
Should You Hold On To BSX Stock Despite Its Premium Valuation? - Finviz
Is Boston Scientific Corp. (BSX) Positioned for Solid, Durable Growth? - Insider Monkey
Boston Scientific Corporation's (NYSE:BSX) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason? - Yahoo Finance
Is Boston Scientific (BSX) one of the best healthcare AI stocks to buy now? - MSN
Is Boston Scientific (BSX) One of the Best Healthcare AI Stocks to Buy Now? - Finviz
UBS Reiterates Buy Rating on Boston Scientific (BSX) - Finviz
UBS reiterates buy rating on Boston Scientific (BSX) - MSN
Is Boston Scientific Corporation stock vulnerable to regulatory risksGold Moves & Free Community Supported Trade Ideas - Улправда
Foster Victor Wealth Advisors LLC Has $19.35 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
Flputnam Investment Management Co. Buys 236,586 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Sold by Congress Asset Management Co. - MarketBeat
How interest rate cuts could boost Boston Scientific Corporation stock2025 Trading Recap & Free Community Supported Trade Ideas - ulpravda.ru
Boston Scientific Corp Stock (BSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.43%
0.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):